| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 1 | 2024 | Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial | Schuler, Martin; CUPPENS, Kristof; Ploenes, Till; Wiesweg, Marcel; Du Pont, Bert; Hegedus, Balazs; Koester, Johannes; Mairinger, Fabian; Darwiche, Kaid; Paschen, Annette; MAES, Brigitte; Vanbockrijck, Michel; Laehnemann, David; Zhao, Fang; Hautzel, Hubertus; Theegarten, Dirk; Hartemink, Koen; Reis, Henning; Baas, Paul; Schramm, Alexander; Aigner, Clemens | Journal Contribution | A1 |
| 2 | 2024 | Immune checkpoint inhibition in early-stage non-small cell lung cancer | CUPPENS, Kristof; Du Pont, Bert; Knegjens, Joost; MAES, Brigitte; Baas, Paul | Journal Contribution | A1 |
| 3 | 2023 | UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN) | Bar, Jair; Peled, Nir; Schokrpur, Shiruyeh; Wolner, Mirjana; Rotem, Ofer; Girard, Nicolas; Nana, Frank Aboubakar; Derijcke, Sofie; Kian, Waleed; Patel, Sandip; Gantz-Sorotsky, Hadas; Zer, Alona; Moskovitz, Mor; Metro, Giulio; Rottenberg, Yakir; Calles, Antonio; Hochmair, Maximilian; CUPPENS, Kristof; Decoster, Lynn; Reck, Martin; Limon, Dror; Rodriguez, Estelamari; Astaras, Christoforos; Bettini, Adrienne; Hafliger, Simon; Addeo, Alfredo | Journal Contribution | A1 |
| 4 | 2023 | The path forward in early-stage lung cancer | CUPPENS, Kristof; Baas, Paul | Journal Contribution | A2 |
| 5 | 2023 | Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1-High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial | Cho, Byoung Chul; Lee, Jong Seok; Wu , Yi-Long; Cicin, Irfan; Dols, Manuel Cobo; Ahn, Myung-Ju; CUPPENS, Kristof; Veillon, Remi; Nadal, Ernest; Dias, Josiane Mourao; Martin, Claudio; Reck, Martin; Garon, Edward B.; Felip, Enriqueta; Paz-Ares, Luis; Mornex, Francoise; Vokes, Everett E.; Adjei, Alex A.; Robinson, Clifford; Sato, Masashi; Vugmeyster, Yulia; Machl, Andreas; Audhuy, Francois; Chaudhary, Surendra; Barlesi, Fabrice | Journal Contribution | A1 |
| 6 | 2023 | Datopotamab Deruxtecan (Dato-DXd) plus Durvalumab ± Carboplatin in Advanced/mNSCLC: Initial Results from Phase 1b TROPION-Lung04 | Papadopoulos, K. P.; Bruno, D.; Kitazono, S.; Murakami, S.; Gutierrez, M.; Wakuda, K.; Spira, A.; CUPPENS, Kristof; Lovick, S.; Hepner, A.; Mak, G.; Waqar, S. N. | Journal Contribution | M |
| 7 | 2023 | Sjogren's Syndrome Caused by PD-1 Inhibition in a Lung Cancer Patient | Caeyman, Aaron; Vandekerckhove, Olivia; Pat, Karin; Wynants, Jokke; Weytjens, Karolien; de Wergifosse, Isabelle; CUPPENS, Kristof | Journal Contribution | A1 |
| 8 | 2023 | Reliability of panel-based mutational signatures for immune-checkpoint-inhibition efficacy prediction in non-small cell lung cancer | Donker, H. C.; CUPPENS, Kristof; FROYEN, Guy; Groen, H. J. M.; Hiltermann, T. J. N.; MAES, Brigitte; Schuuring, E.; Volders, P. -J.; Lunter, G. A.; van Es, B. | Journal Contribution | A1 |
| 9 | 2023 | Liquid Biopsy in Early-Stage Lung Cancer: Current and Future Clinical Applications | Vandekerckhove, Olivia; CUPPENS, Kristof; Pat, Karin; Du Pont, Bert; FROYEN, Guy; MAES, Brigitte | Journal Contribution | A1 |
| 10 | 2022 | Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment | Agbarya, Abed; Shalata, Walid; Addeo, Alfredo; Charpidou, Andriani; CUPPENS, Kristof; Brustugun, Odd Terje; Rajer, Mirjana; Jakopovic, Marco; Marinca, Mihai, V; Pluzanski, Adam; Hiltermann, Jeroen; Araujo, Antonio | Journal Contribution | A1 |
| 11 | 2022 | Open-label, dose escalation, phase I/II study to assess safety, tolerability, immunogenicity and preliminary clinical activity of the therapeutic cancer vaccine PDC*lung01 with or without anti-programmed death-1 (PD-1) treatment in patients with non-small cell lung cancer (NSCLC) | Vansteenkiste, J. F.; Demedts, I.; Pons-Tostivint, E.; Biesma, B.; Borm, F.; Colinet, B.; CUPPENS, Kristof; Derijcke, S.; Greillier, L.; Juergens, J.; Moro-Sibilot, D.; Perol, M.; Sebastian, M.; Skrzypski, M.; Theelen, W.; Van De Kerkhove, C.; Collodoro, M.; Plumas, J.; Debruyne, C.; Sibille, A. | Journal Contribution | M |
| 12 | 2022 | Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib | Awada, Ahmad; Berghmans, Thierry; Clement, Paul M.; CUPPENS, Kristof; De Wilde, Bram; Machiels, Jean-Pascal; Pauwels , Patrick; Peeters , Marc; Rottey, Sylvie; Van Cutsem , Eric | Journal Contribution | A1 |
| 13 | 2022 | A prospective, multicenter, noninterventional study of decision factors in the first-line treatment of metastatic non-small cell lung cancer | Sibille, Anne; Bustin, Frederique; Carestia, Luciano; Catala, Gaetan; Compere, Christophe; CUPPENS, Kristof; Colinet, Benoit; Coulon, Stephanie; De Brucker, Nele; Decoster, Lore; Decoster, Lynn; Demedts, Ingel; Derijcke, Sofie; Deschepper, Koen; Galdermans, Danny; Janssens, Annelies; Ocak, Sebahat; Oyen, Christel; Pat, Karin; Pieters, Thierry; Pruniau, Vincent; Surmont, Veerle; Vandekeere, Saar; Vansteenkiste, Johan | Journal Contribution | A1 |
| 14 | 2022 | Uncommon EGFR mutations on osimertinib, real-life data (UNICORN study): Updated results, brain efficacy, and resistance mechanisms | Bar, Jair; Peled, Nir; Schokrpur, Shiruyeh; Dudnik, Elizabeth; Wollner, Mira; Girard, Nicolas; Nana, Frank Aboubakar; Derijcke, Sofie; Kian, Waleed; Patel, Sandip P.; Sorotsky, Hadas Yocheved Gantz; Zer, Alona; Moskovitz, Mor; Metro, Giulio; Rottenberg, Yakir; Calles, Antonio; Hochmair, Maximilian; CUPPENS, Kristof; Decoster, Lynn; Addeo, Alfredo | Journal Contribution | M |
| 15 | 2022 | A randomized, multicentric phase II study of preoperative nivolumab plus relatlimab or nivolumab in patients with resectable non-small cell lung cancer (NEOpredict-Lung) | Schuler, M. H. H.; CUPPENS, Kristof; Ploenes, T.; Vanbockrijck, M.; Wiesweg, M.; Darwiche, K.; Schramm, A.; MAES, Brigitte; Hegedus, B.; Schildhaus, H-U.; Hautzel, H.; Theegarten, D.; Baas, P.; Hartemink, K.; Du Pont, B.; Aigner, C. | Journal Contribution | M |
| 16 | 2022 | HLA-I diversity and tumor mutational burden by comprehensive next-generation sequencing as predictive biomarkers for the treatment of non-small cell lung cancer with PD-(L)1 inhibitors | CUPPENS, Kristof; Baas, Paul; GEERDENS, Ellen; Cruys, Bert; FROYEN, Guy; Decoster, Lynn; THOMEER, Michiel; MAES, Brigitte | Journal Contribution | A1 |
| 17 | 2020 | 1037P Tumour mutational burden and HLA diversity by TruSight oncology 500 (TSO500) next generation sequencing panel and clinical outcome in non-small cell lung cancer | CUPPENS, Kristof; FROYEN, Guy; Cruys, B.; GEERDENS, Ellen; Zhang, S.; Zhang, B.; Decoster, L.; THOMEER, Michiel; MAES, Brigitte | Journal Contribution | M |
| 18 | 2019 | Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests | Topalovic, Marko; Das, Nilakash; Burgel, Pierre-Regis; DAENEN, Marc; Derom, Eric; Haenebalcke, Christel; Janssen, Rob; Kerstjens, Huib A. M.; Liistro, Giuseppe; Louis, Renaud; Ninane, Vincent; Pison, Christophe; Schlesser, Marc; Vercauter, Piet; Vogelmeier, Claus F.; Wouters, Emiel; Wynants, Jokke; Janssens, Wim; De Pauw, R.; Depuydt, C.; Haenebalcke, C.; Muyldermans, S.; Ringoet, V.; Stevens, D.; Bayat, S.; Benet, J.; Catho, E.; Claustre, J.; Fedi, A.; Ferjani, M. A.; Guzun, R.; Isnard, M.; Nicolas, S.; Pierret, T.; Pison, C.; Rouches, S.; Wuyam, B.; Corhay, J. L.; Guiot, J.; Ghysen, K.; Renaud, L.; Sibille, A.; De La Barriere, H.; Charpentier, C.; Corhut, S.; Hamdan, K. A.; Schlesser, M.; Wirtz, G.; Alabadan, E.; Birsen, G.; Burgel, P. R.; Chohra, A.; Hamard, C.; Lemarie, B.; Lothe, M. N.; Martin, C.; Sainte-Marie, A. C.; Sebane, L.; Berk, Y.; de Brouwer, B.; Kerkhoff, J.; Spaanderman, A.; Stegers, M.; Termeer, A.; van Grimbergen, I.; van Veen, A.; van Ruitenbeek, L.; Vermeer, L.; Zaal, R.; Zijlker, M.; AUMANN, Joseph; CUPPENS, Kristof; Degraeve, D.; DEMUYNCK, Koen; Dieriks, B.; Pat, Kris; SPAAS, Luc; Van Puijenbroek, R.; Weytjens, K.; Wynants, J.; Adam, V.; Berendes, B. J.; Hardeman, E.; Jordens, P.; Munghen, E.; Tournoy, K.; Vercauter, P.; Alame, T.; Bruyneel, M.; Gabrovska, M.; Muylle, I.; Ninane, V.; Rozen, D.; Rummens, P.; Van den Broecke, S.; Froidure, A.; Gohy, S.; Liistro, G.; Pieters, T.; Pilette, C.; Pirson, F.; Kerstjens, H.; Van den Berge, M.; Ten Hacken, N.; Duiverman, M.; Koster, D.; Vosse, B.; Conemans, L.; Maus, M.; Bischoff, M.; Rutten, M.; Agterhuis, D.; Sprooten, R.; Beutel, B.; Jerrentrup, A.; Klemmer, A.; Viniol, C.; Vogelmeier, C.; Bode, H.; Dooms, C.; Gullentops, D.; Nackaerts, K.; Rutens, D.; Wauters, E.; Wuyts, W.; Derom, E.; Dobbelaere, S.; Loof, S.; Serry, G.; Putman, B.; Van Acker, L.; Vandeweygaerde, Y.; Criel, M.; Daenen, Michaël; Gubbelmans, R.; Klerkx, S.; Michiels, E.; THOMEER, Michiel; Vanhauwaert, A. | Journal Contribution | A1 |